Mitochondrial DNA insertion into brain cells’ nucleus linked to early death
Bharti Jayshankar August 30, 2024: A recent study has found that the insertion of mitochondrial DNA into the nucleus of brain cells, a
Drugs
Health
Medical
Drugs
Health
Medical
Live kidney donation is safer than previously thought
Bharti Jayshankar August 30, 2024: Kidney donors face a lower risk of death than previously believed, according to a new research. Data from
Drugs
Health
Pharma
Cigarette smoking may help fight Parkinson’s disease: Harvard research
Smoking cigarettes may protect humans from neurodegeneration and prevent the accumulation of a key Parkinson’s-associated protein in the brain, new research on mice
Drugs
Health
Pharma
US smokers need photo ID to prove new age limit set by the FDA
The US drug regulator raised the age limit of people who want to buy tobacco products by three years to 30, and retailers
Drugs
Health
Pharma
Neurocine’s mid-stage trial drug cuts schizophrenia severity symptoms
US-based Neurocrine Biosciences’ trial drug for treating schizophrenia reduced the severity of the disease symptoms in a mid-stage study of 210 adult participants.
Drugs
Health
Pharma
‘Culture of comparison’ fuelling parental stress: US Surgeon General
An intensifying culture of comparison, that defines success and fulfilment, is behind unrealistic expectations that US parents and kids are forced to chase
Drugs
Health
Pharma
Illumina’s DNA sequencing cancer tests to check 500 genes get US nod
The US Federal Drug Administration approved Illumina Inc.’s DNA sequencing cancer tests that check more than 500 genes in a tumour to help
Drugs
Health
Pharma
Global health body appeals for $87.4 million to contain mpox spread
The World Health Organization has appealed for $87.4 million over the next six months to stop and contain the current global outbreak of
Drugs
Health
Pharma
McKesson Corp., to acquire Core Ventures for $2.4 billion in cash
McKesson Corporation, the ninth-largest company by revenue in the US, will acquire Community Oncology Revitalization Enterprise Ventures, for $2.4 billion in cash to expand its
Drugs
Health
Pharma
Regulator okays Insulet’s insulin pump in US to treat type 2 diabetes
Insulet Corporation, a tubeless insulin pump maker, got clearance from the US Food and Drug Administration to add diabetes type 2 adult patients